Citation

Caley CF, Perriello E, Golden J. Ment. Health Clin. 2018; 8(3): 138-147.

Affiliation

Clinical Research Assistant, Burlingame Center for Psychiatric Research and Education, Institute of Living, Hartford, Connecticut.

Copyright

(Copyright © 2018, College of Psychiatric and Neurologic Pharmacists)

DOI

10.9740/mhc.2018.05.138

PMID

29955559

PMCID

PMC6007633

Abstract

INTRODUCTION: In January 2008 the US Food and Drug Administration issued a warning to healthcare professionals about the potential for an increased risk of suicidal thinking and behavior associated with antiepileptic drugs (AEDs). Given that AEDs are important for treating bipolar disorder (BD), a better understanding of suicide-related events is necessary.

METHODS: A PubMed search was performed using the following search terms: anticonvulsant OR valpro* OR carbamazepine OR lamotrigine OR oxcarbazepine OR topiramate AND bipolar AND suicid*. The objective was to identify published investigations reporting rate and/or risk data of suicide-related outcomes in BD patients treated with AED monotherapy.

RESULTS: The search identified 323 reviewable citations, with 13 of these studies (4.0%) being reviewed. Valproate was studied most often, and lithium treatment was frequently used as a reference group. Carbamazepine and lamotrigine had small treatment exposure durations. Suicide attempts and suicide deaths were studied the most; a few trials investigated suicidal thinking and/or hospitalizations for suicidal behavior. Suicide attempt rates occurred in the following order: no treatment > carbamazepine > valproate > lithium, while suicide death rates were: no treatment > valproate > lithium > carbamazepine. For valproate, the risk of suicide attempts and suicide death appeared higher than lithium, but lower than no treatment.

DISCUSSION: Investigating suicide-related events for AEDs in BD is difficult; more data are necessary for valproate, carbamazepine, and lamotrigine. An improved understanding of AED treatment and suicide-related events in BD may help pharmacists become more effective at supporting their patients with BD.

Language: en

Keywords

bipolar disorder; carbamazepine; lamotrigine; suicide attempt; suicide completion; valproate